Molecularly Targeted Therapies for Malignant Gliomas

作者: Andreas A. Argyriou , Haralabos P. Kalofonos

DOI: 10.2119/MOLMED.2008.00123

关键词:

摘要: This review critically evaluates current knowledge of molecularly targeted therapies malignant gliomas. Various single-agent therapies, including growth and survival, have been evaluated in clinical trials but failed to demonstrate a significant survival benefit compared with standard treatment regimens. The efficacy multitargeted kinase inhibitors or combinations single-targeted is promising strategy, requires additional evaluation before definitive conclusions can be made. Important areas for further research include the assessment serum tissue biomarkers, elucidation prognostic molecular markers, determination whether mechanism action drug appropriate genetic alterations observed within individual tumors.

参考文章(65)
Jorge L Eller, Sharon L Longo, Michele M Kyle, Daniel Bassano, Daniel J Hicklin, Gregory W Canute, None, Anti-epidermal growth factor receptor monoclonal antibody cetuximab augments radiation effects in glioblastoma multiforme in vitro and in vivo. Neurosurgery. ,vol. 56, pp. 155- 162 ,(2005) , 10.1227/01.NEU.0000145865.25689.55
Shizuo Shirai, Shingo Takano, Hideo Suzuki, Shinichi Kondo, Tooru Maruno, Yoshihiko Yoshii, Tadao Nose, Concentration of Vascular Endothelial Growth Factor in the Serum and Tumor Tissue of Brain Tumor Patients Cancer Research. ,vol. 56, pp. 2185- 2190 ,(1996)
John H. Sampson, Gamal Akabani, Gary E. Archer, Darell D. Bigner, Mitchel S. Berger, Allan H. Friedman, Henry S. Friedman, James E. Herndon II, Sandeep Kunwar, Steve Marcus, Roger E. McLendon, Alison Paolino, Kara Penne, James Provenzale, Jennifer Quinn, David A. Reardon, Jeremy Rich, Timothy Stenzel, Sandra Tourt-Uhlig, Carol Wikstrand, Terence Wong, Roger Williams, Fan Yuan, Michael R. Zalutsky, Ira Pastan, Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-α and a Mutated form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors Journal of Neuro-oncology. ,vol. 65, pp. 27- 35 ,(2003) , 10.1023/A:1026290315809
Adrian Merlo, Genes and pathways driving glioblastomas in humans and murine disease models. Neurosurgical Review. ,vol. 26, pp. 145- 158 ,(2003) , 10.1007/S10143-003-0267-8
Emel Yaman, Suleyman Buyukberber, Aytug Uner, Ugur Coskun, Muge Akmansu, Mustafa Benekli, Deniz Yamac, Banu Ozturk, Ali Osman Kaya, Ramazan Yıldız, Secıl Ozkan, Nazan Gunel, Temozolomide in Newly Diagnosed Malignant Gliomas: Administered Concomitantly with Radiotherapy, and Thereafter as Consolidation Treatment Onkologie. ,vol. 31, pp. 309- 313 ,(2008) , 10.1159/000127252
Dong-chul Kang, Zao-zhong Su, Devanand Sarkar, Luni Emdad, David J. Volsky, Paul B. Fisher, Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1 Gene. ,vol. 353, pp. 8- 15 ,(2005) , 10.1016/J.GENE.2005.04.006
Zbigniew Wygoda, Dorota Kula, Grażyna Bierzyńska-Macyszynz, Dawid Larysz, Michał Jarząb, Paweł Właszczųk, Piotr Baż Owski, Maciej Wojtacha, Adam Rudnik, Tomasz Stępień, Wojciech Kaspera, Aleksandra Etmańska, Krzysztof Składowski, Rafał Tarnawski, Danuta Kokocińska, Barbara Jarząb, Use of monoclonal anti-EGFR antibody in the radioimmunotherapy of malignant gliomas in the context of EGFR expression in grade III and IV tumors. Hybridoma. ,vol. 25, pp. 125- 132 ,(2006) , 10.1089/HYB.2006.25.125
Luni Emdad, Devanand Sarkar, Zao-Zhong Su, Seok-Geun Lee, Dong-Chul Kang, Jeffrey N. Bruce, David J. Volsky, Paul B. Fisher, Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacology & Therapeutics. ,vol. 114, pp. 155- 170 ,(2007) , 10.1016/J.PHARMTHERA.2007.01.010
Caroline Houillier, Julie Lejeune, Alexandra Benouaich‐Amiel, Florence Laigle‐Donadey, Emmanuelle Criniere, Karima Mokhtari, Joelle Thillet, Jean‐Yves Delattre, Khe Hoang‐Xuan, Marc Sanson, None, Prognostic impact of molecular markers in a series of 220 primary glioblastomas. Cancer. ,vol. 106, pp. 2218- 2223 ,(2006) , 10.1002/CNCR.21819
A. A. Adjei, Blocking oncogenic Ras signaling for cancer therapy. Journal of the National Cancer Institute. ,vol. 93, pp. 1062- 1074 ,(2001) , 10.1093/JNCI/93.14.1062